Insights Blog

This conversation aims to demystify the complex world of NGS testing, providing patients, caregivers, and healthcare professionals with a clearer understanding of how these powerful tools are revolutionizing cancer prevention, treatment, and long-term management.

We highlight emerging disease-driving pathways in development that have the potential to move us beyond symptom management and toward truly disease-modifying treatment.

Precision diagnostics broke out in 2025—and life science tools companies are racing toward the clinic as the line between tools and diagnostics rapidly blurs.

We spoke with Yi Kong, PhD, Healthcare Executive. Yi heads up Greater China operations at a major Life Science and Diagnostics company.

2025 concluded with continued investment in key precision medicine modalities.

Now in its second year, Women of Precision Medicine focuses on the leaders behind that progress, spotlighting the women shaping precision medicine today.